Angiotensin subtype-1 receptor (AT1R) influences inflammatory processes through enhancing signal transducer and activator of transcription proteins 3 (STAT3) signal …
BACKGROUND:: The Losartan Intervention For End-point reduction in hypertension (LIFE) study found that a losartan-based regimen, compared with an atenolol-based regimen …
Angiotensin-II regulates vascular tone, stimulates the release of pro-inflammatory cytokines, activates NF-κB, increases oxidant stress, and suppresses nitric oxide synthesis, and thus, it …
CS Moran, B Cullen, JH Campbell… - Journal of vascular …, 2009 - karger.com
Abstract Background and Aims: Osteoprotegerin (OPG) has been associated with abdominal aortic aneurysm (AAA) expansion. Angiotensin II (AngII) receptor blockade has been shown …
In this study we introduce a rescoring method to improve the accuracy of docking programs against mPGES-1. The rescoring method developed is a result of extensive computational …
D Santovito, A Mezzetti, F Cipollone - Current opinion in lipidology, 2009 - journals.lww.com
Cyclooxygenase and prostaglandin synthases: roles in plaque... : Current Opinion in Lipidology Cyclooxygenase and prostaglandin synthases: roles in plaque stability and instability in …
J Yang, X Yang, X Meng, M Dong, T Guo, J Kong… - International journal of …, 2015 - Elsevier
Background and objective We recently found that exogenous angiotensin-(1-7)[Ang-(1-7)] inhibits Angiotensin II (Ang-II)-induced atherosclerotic lesion formation and enhances …
M Hermann, F Ruschitzka - Internal medicine journal, 2006 - Wiley Online Library
The introduction of selective cyclooxygenase‐2 inhibitors offered the promise of similar efficacy in pain control without the gastrointestinal effects associated with non‐selective non …
K Yamaguchi, T Wakatsuki, T Soeki, T Niki… - Circulation …, 2014 - jstage.jst.go.jp
Background: Telmisartan has unique pleiotropic effects in addition to renin-angiotensin system (RAS)-inhibition effects. The aim of this study was to evaluate the effects of …